Esketamine Prevents Treatment-Resistant Depression Relapse.

OPEN Foundation
October 22, 2019

Slomski, A. (2019). Esketamine Prevents Treatment-Resistant Depression Relapse. 22, 322(16), 1544-1544.
Link to full text

OPEN Foundation

Share This Post

get the latest

The OPEN Minded Newsletter keeps you informed about the latest psychedelic research & news, articles, exclusive events, job opportunities, programmes, and free resources!

By clicking SUBSCRIBE, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.

Recent articles & news

Music in Psychedelic Practices – From the Field

Clinical Trial into Psilocybin Therapy for Psychological Distress in Palliative Care, PsyPal, Receives Medical Ethical Authorisation, with Conditions

Comparing Psychedelic-Assisted Therapy with Traditional Therapy for Mental Illnesses – Part 2

Harnessing Psychedelics for Neurofeedback: A New Frontier in Executive Function Improvement

Psychedelics vs. Traditional Treatments —How Do They Stack Up for Mental Health Disorders? – Part 1

Dutch Psychedelic Practices Shaped by Culture and Law

Do Psychedelic States merely create comforting delusions?

Lessons on Psychedelic Harm Reduction with PsyCare NL – From the field

The Role of Psychedelics in Palliative Care: Real-World Cases – Dr. Houman Farzin, M.D.

Esketamine Prevents Treatment-Resistant Depression Relapse.

OPEN Foundation

Share This Post

get the latest

Recent articles & news

OPEN

ABOUT

EVENTS

RESOURCES

PROGRAMMES

ACTIONS

Esketamine Prevents Treatment-Resistant Depression Relapse.

OPEN Foundation

Share This Post

get the latest

Recent articles & news

OPEN

ABOUT

EVENTS

RESOURCES

PROGRAMMES

ACTIONS

interested in becoming a trained psychedelic-assisted therapist?

get the latest updates